Revised SPC: Revatio (sildenafil) preparations

SPC now states that, outside its authorised indications, sildenafil should not be used in neonates with persistent pulmonary hypertension of the newborn as risks outweigh the benefits. Sildenafil is not licensed for use in patients <1 year.

Source:

electronic Medicines compendium